© 1995 American Heart Association, Inc.
Articles |
Activation of Tissue Factor–Induced Coagulation and Endothelial Cell Dysfunction in Non–Insulin-Dependent Diabetic Patients With Microalbuminuria
From the Department of Internal Medicine, Awaji-Hokudan Public Clinic (K.K.), and the Department of Internal Medicine (K.K., T. Matsuo) and Central Laboratory (H.K., M.M.), Hyogo Prefectural Awaji Hospital, Hyogo, and the Clinical Laboratory (T.S.) and Research Institute (T. Miyata), National Cardiovascular Center, Suita, Japan.
Correspondence to Dr Kazuomi Kario, 480-2, Ikuha, Hokudan, Tsuna, Hyogo, 656-16, Japan.
Abstract We studied the relationships between albuminuria, tissue factor–induced coagulation, and endothelial cell dysfunction in 67 patients with non–insulin-dependent diabetes mellitus (NIDDM) who were divided into three groups on the basis of their urinary albumin excretion rate (AER). To assess the early phase of tissue factor–induced coagulation, activated factor VII (FVIIa) levels in plasma were measured by a direct fluorogenic assay. As markers of endothelial cell dysfunction, levels of von Willebrand factor (vWF), tissue-type plasminogen activator–plasminogen activator inhibitor–1 (TPA–PAI-1) complex, PAI-1, and tissue factor pathway inhibitor (TFPI) were measured. FVIIa levels were increased in normoalbuminuric NIDDM patients (AER <15 µg/min) when compared with normal control subjects. This FVIIa increase was accompanied by an increase in thrombin–antithrombin III complex (TAT) levels, indicating increased activation of coagulation even in normoalbuminuric patients. In NIDDM patients with microalbuminuria (AER=15-200 µg/min), the FVIIa level, the FVIIa–FVII antigen (Ag) ratio (an indicator of activation of FVII zymogen to FVIIa), and the TAT level were further increased. This group also had higher levels of endothelial cell–derived factors (vWF, TPA–PAI-1 complex, and PAI-1) than the control group. The levels of endothelial cell–derived factors (including TFPI) were highest in the NIDDM patients with overt albuminuria (AER>200 µg/min). In all 67 diabetic patients, AER showed a strong positive correlation with FVIIa (r=.574, P<.0001) and a weakly but still significant correlation with FVIIa-FVII:Ag (r=.365, P=.01), vWF (r=.315, P<.01), and TAT (r=.323, P<.01). FVIIa showed a weaker correlation with vWF (r=.244, P<.05). FVIIa generation concomitant with an increase in AER is probably due to endothelial cell damage. Increased plasma FVIIa levels would produce hypercoagulability in NIDDM patients with microalbuminuria and thus may be a risk for cardiovascular disease.
Key Words: non–insulin-dependent diabetes mellitus • microalbuminuria • endothelial cell dysfunction • tissue factor–induced coagulation • activated factor VII
This article has been cited by other articles:
 |
|
 |
|
  A. Kaukinen, A.-M. Kuusniemi, I. Lautenschlager, and H. Jalanko Glomerular endothelium in kidneys with congenital nephrotic syndrome of the Finnish type (NPHS1) Nephrol. Dial. Transplant., April 1, 2008; 23(4): 1224 - 1232. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Boden, V. R. Vaidyula, C. Homko, P. Cheung, and A. K. Rao Circulating Tissue Factor Procoagulant Activity and Thrombin Generation in Patients with Type 2 Diabetes: Effects of Insulin and Glucose J. Clin. Endocrinol. Metab., November 1, 2007; 92(11): 4352 - 4358. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Authors/Task Force Members, L. Ryden, E. Standl, M. Bartnik, G. V. d. Berghe, J. Betteridge, M.-J. de Boer, F. Cosentino, B. Jonsson, M. Laakso, et al. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: full text: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD) Eur. Heart J. Suppl., June 1, 2007; 9(suppl_C): C3 - C74. [Full Text] [PDF]
|
|
|
|
 |
|
 Authors/Task Force Members, L. Ryden, E. Standl, M. Bartnik, G. Van den Berghe, J. Betteridge, M.-J. de Boer, F. Cosentino, B. Jonsson, M. Laakso, et al. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD) Eur. Heart J., January 1, 2007; 28(1): 88 - 136. [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Mostaza, C. Suarez, L. Manzano, M. Cairols, F. Garcia-Iglesias, J. Sanchez-Alvarez, J. Ampuero, D. Godoy, A. Rodriguez-Samaniego, M. A. Sanchez-Zamorano, et al. Relationship between Ankle-Brachial Index and Chronic Kidney Disease in Hypertensive Patients with No Known Cardiovascular Disease J. Am. Soc. Nephrol., December 1, 2006; 17(12_suppl_3): S201 - S205. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. R. Vaidyula, A. K. Rao, M. Mozzoli, C. Homko, P. Cheung, and G. Boden Effects of Hyperglycemia and Hyperinsulinemia on Circulating Tissue Factor Procoagulant Activity and Platelet CD40 Ligand Diabetes, January 1, 2006; 55(1): 202 - 208. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Creager, T. F. Luscher, F. Cosentino, and J. A. Beckman Diabetes and Vascular Disease: Pathophysiology, Clinical Consequences, and Medical Therapy: Part I Circulation, September 23, 2003; 108(12): 1527 - 1532. [Full Text] [PDF]
|
|
|
|
|
|
A. Faggiano, R. Pivonello, S. Spiezia, M. C. De Martino, M. Filippella, C. Di Somma, G. Lombardi, and A. Colao Cardiovascular Risk Factors and Common Carotid Artery Caliber and Stiffness in Patients with Cushing's Disease during Active Disease and 1 Year after Disease Remission J. Clin. Endocrinol. Metab., June 1, 2003; 88(6): 2527 - 2533. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. L. Hillege, V. Fidler, G. F.H. Diercks, W. H. van Gilst, D. de Zeeuw, D. J. van Veldhuisen, R. O.B. Gans, W. M.T. Janssen, D. E. Grobbee, P. E. de Jong, et al. Urinary Albumin Excretion Predicts Cardiovascular and Noncardiovascular Mortality in General Population Circulation, October 1, 2002; 106(14): 1777 - 1782. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Kluft and J. Jespersen Review: Diabetes as a procoagulant condition The British Journal of Diabetes & Vascular Disease, September 1, 2002; 2(5): 358 - 362. [Abstract] [PDF]
|
|
|
|
 |
|
 P. B. Leurs, R. P. Stolk, K. Hamulyak, R. van Oerle, D. E. Grobbee, and B. H. R. Wolffenbuttel Tissue Factor Pathway Inhibitor and Other Endothelium-Dependent Hemostatic Factors in Elderly Individuals With Normal or Impaired Glucose Tolerance and Type 2 Diabetes Diabetes Care, August 1, 2002; 25(8): 1340 - 1345. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Beckman, M. A. Creager, and P. Libby Diabetes and Atherosclerosis: Epidemiology, Pathophysiology, and Management JAMA, May 15, 2002; 287(19): 2570 - 2581. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Jager, V. W.M. van Hinsbergh, P. J. Kostense, J. J. Emeis, G. Nijpels, J. M. Dekker, R. J. Heine, L. M. Bouter, and C. D.A. Stehouwer C-Reactive Protein and Soluble Vascular Cell Adhesion Molecule-1 Are Associated With Elevated Urinary Albumin Excretion but Do Not Explain Its Link With Cardiovascular Risk Arterioscler Thromb Vasc Biol, April 1, 2002; 22(4): 593 - 598. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Samad, M. Pandey, and D. J. Loskutoff Regulation of tissue factor gene expression in obesity Blood, December 1, 2001; 98(12): 3353 - 3358. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. K. M. T. Zaman, S. Fujii, H. Sawa, D. Goto, N. Ishimori, K. Watano, T. Kaneko, T. Furumoto, T. Sugawara, I. Sakuma, et al. Angiotensin-Converting Enzyme Inhibition Attenuates Hypofibrinolysis and Reduces Cardiac Perivascular Fibrosis in Genetically Obese Diabetic Mice Circulation, June 26, 2001; 103(25): 3123 - 3128. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Calles-Escandon and M. Cipolla Diabetes and Endothelial Dysfunction: A Clinical Perspective Endocr. Rev., February 1, 2001; 22(1): 36 - 52. [Abstract] [Full Text]
|
|
|
|
|
|
L. Tarnow, C. D. A. Stehouwer, J. J. Emeis, O. Poirier, F. Cambien, B. V. Hansen, and H.-H. Parving Plasminogen activator inhibitor-1 and apolipoprotein E gene polymorphisms and diabetic angiopathy Nephrol. Dial. Transplant., May 1, 2000; 15(5): 625 - 630. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Pernerstorfer, P. Stohlawetz, U. Hollenstein, L. Dzirlo, H.-G. Eichler, S. Kapiotis, B. Jilma, and W. Speiser Endotoxin-Induced Activation of the Coagulation Cascade in Humans : Effect of Acetylsalicylic Acid and Acetaminophen Arterioscler Thromb Vasc Biol, October 1, 1999; 19(10): 2517 - 2523. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Jager, P. J. Kostense, H. G. Ruhe, R. J. Heine, G. Nijpels, J. M. Dekker, L. M. Bouter, and C. D. A. Stehouwer Microalbuminuria and Peripheral Arterial Disease Are Independent Predictors of Cardiovascular and All-Cause Mortality, Especially Among Hypertensive Subjects : Five-year Follow-up of the Hoorn Study Arterioscler Thromb Vasc Biol, March 1, 1999; 19(3): 617 - 624. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F Galtier-Dereure, C Biron, M Vies, V Bourgeois, J-F Schved, and J Bringer Vascular complications of diabetes mellitus: what role for phospholipid-binding antibodies? Lupus, September 1, 1998; 7(7): 469 - 474. [Abstract] [PDF]
|
|
|
|
 |
|
 F. Samad, M. Pandey, and D. J. Loskutoff Tissue factor gene expression in the adipose tissues of obese mice PNAS, June 23, 1998; 95(13): 7591 - 7596. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Loskutoff and F. Samad The Adipocyte and Hemostatic Balance in Obesity : Studies of PAI-1 Arterioscler Thromb Vasc Biol, January 1, 1998; 18(1): 1 - 6. [Full Text] [PDF]
|
|
|
|
|
|
K. Kario, N. Kanai, S. Nishiuma, T. Fujii, K. Saito, T. Matsuo, M. Matsuo, and K. Shimada Hypertensive Nephropathy and the Gene for Angiotensin-Converting Enzyme Arterioscler Thromb Vasc Biol, February 1, 1997; 17(2): 252 - 256. [Abstract] [Full Text]
|
|
|
|
|
|
K. Kario, T. Matsuo, H. Kobayashi, R. Asada, and M. Matsuo `Silent' Cerebral Infarction Is Associated With Hypercoagulability, Endothelial Cell Damage, and High Lp(a) Levels in Elderly Japanese Arterioscler Thromb Vasc Biol, June 1, 1996; 16(6): 734 - 741. [Abstract] [Full Text]
|
|
|
|
|
|
K. Kario, T. Matsuo, H. Kobayashi, M. Matsuo, T. Sakata, T. Miyata, and K. Shimada Factor VII Hyperactivity and Endothelial Cell Damage Are Found in Elderly Hypertensives Only When Concomitant With Microalbuminuria Arterioscler Thromb Vasc Biol, March 1, 1996; 16(3): 455 - 461. [Abstract] [Full Text]
|
|
|
|
|
|
A. Jager, V. W.M. van Hinsbergh, P. J. Kostense, J. J. Emeis, G. Nijpels, J. M. Dekker, R. J. Heine, L. M. Bouter, and C. D.A. Stehouwer C-Reactive Protein and Soluble Vascular Cell Adhesion Molecule-1 Are Associated With Elevated Urinary Albumin Excretion but Do Not Explain Its Link With Cardiovascular Risk Arterioscler Thromb Vasc Biol, April 1, 2002; 22(4): 593 - 598. [Abstract] [Full Text] [PDF]
|
|